Editoriali
Vaccinazione anti-HPV: alcuni interrogativi per il pediatra
Simona Di Mario, Vittorio Basevi, Nicola Magrini
SaPeRiDoc - CeVEAS, Modena
Maggio 2007 - pagg. 279
Classificazione MeSH
Bibliografia
1. Agenzia Italiana del Farmaco. Il vaccino per il cancro della cervice.
Medico e Bambino pagine elettroniche 2007;10. Disponibile all’URL:
http://www.medicoebambino.com/index.php?id=IPS0704_10.html (ultimo
accesso 09.05.2007).
2. Gostin LO, DeAngelis CD. Mandatory HPV vaccination: public health vs private wealth. JAMA 2007;297:1921-3.
3. AAVV. Flogging gardasil. Nat Biotechnol 2007;25:261.
4. Coombes R. Life saving treatment or giant experiment? BMJ 2007;334: 721-3.
5. Sawaya GF, Smith-McCune K. HPV vaccination-more answers, more questions. N Engl J Med 2007;356:1991-3.
6. Lehtinen M, Apter D, Dubin G, et al. Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing. Int J STD AIDS 2006;17: 517-21.
7. Kudjawu Y, Lévy-Bruhl D, Pastore Celentano L , et al. on behalf of the VENICE working group. The current status of HPV and rotavirus vaccines in national immunisation schedules in the EU - preliminary results of a VENICE survey. Disponibile all’URL: http://www.eurosurveillance.org/ ew/2007/070426.asp#1 (ultimo accesso 09.05.2007).
8. Gallo T, Binkin N, Baldissera S, et al. La diffusione dell’attività di diagnosi precoce in Italia per lo screening cervicale, mammografico e colorettale (Studio PASSI, 2005). Quinto Rapporto dell’Osservatorio nazionale screening 2006. A cura di Rosselli Del Turco M, Zappa M, pp.140-6.
9. Berrington de Gonzalez A, Green J. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2007;120:885-91.
10. Warren KS, Mosteller F. Doing more good than harm: the evaluation of health care interventions. Annals of the New York Academy of Science, 1993.
11. Sheldon T. Drug company campaign adds to pressure on Dutch doctors to vaccinate against HPV. BMJ 2007;334:819.
2. Gostin LO, DeAngelis CD. Mandatory HPV vaccination: public health vs private wealth. JAMA 2007;297:1921-3.
3. AAVV. Flogging gardasil. Nat Biotechnol 2007;25:261.
4. Coombes R. Life saving treatment or giant experiment? BMJ 2007;334: 721-3.
5. Sawaya GF, Smith-McCune K. HPV vaccination-more answers, more questions. N Engl J Med 2007;356:1991-3.
6. Lehtinen M, Apter D, Dubin G, et al. Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing. Int J STD AIDS 2006;17: 517-21.
7. Kudjawu Y, Lévy-Bruhl D, Pastore Celentano L , et al. on behalf of the VENICE working group. The current status of HPV and rotavirus vaccines in national immunisation schedules in the EU - preliminary results of a VENICE survey. Disponibile all’URL: http://www.eurosurveillance.org/ ew/2007/070426.asp#1 (ultimo accesso 09.05.2007).
8. Gallo T, Binkin N, Baldissera S, et al. La diffusione dell’attività di diagnosi precoce in Italia per lo screening cervicale, mammografico e colorettale (Studio PASSI, 2005). Quinto Rapporto dell’Osservatorio nazionale screening 2006. A cura di Rosselli Del Turco M, Zappa M, pp.140-6.
9. Berrington de Gonzalez A, Green J. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2007;120:885-91.
10. Warren KS, Mosteller F. Doing more good than harm: the evaluation of health care interventions. Annals of the New York Academy of Science, 1993.
11. Sheldon T. Drug company campaign adds to pressure on Dutch doctors to vaccinate against HPV. BMJ 2007;334:819.